Freezing Corpses: Could Death Become a Temporary State?

## Introduction

## Current Tissue Freezing Techniques

Vitrification is currently the leading method for preserving human tissue without forming damaging ice crystals. The process mixes high‑concentration cryoprotectants—substances that prevent water from crystallizing—and rapidly cools the specimen to below –130 °C, turning it into a glass‑like state. Vitrification is routinely used for embryos, oocytes, and small organ fragments such as kidney slices for research purposes. In surgical practice, deep hypothermia is applied to reduce metabolic demand during complex cardiac and neurosurgical procedures, allowing surgeons to temporarily halt heart and brain function and then gradually restore it. While these applications demonstrate partial success, preserving an entire brain still requires breakthroughs in uniformly delivering cryoprotectants throughout the dense neural tissue.

## Probabilities of Preserving Neural Information

The medRxiv survey asked physicians to estimate the chance of preserving neural information, resulting in an average figure of 25.5 %. This estimate reflects optimism tempered by considerable uncertainty. Success depends on several variables: cooling rate, cryoprotectant formulation, and brain size. Notably, neurologists tended to assign higher probabilities than anesthesiologists, indicating differing perspectives on underlying mechanisms. The moderate average suggests that the concept remains experimental, and extensive long‑term studies are needed to determine whether consciousness and memory can truly be restored after thawing.

## Physician Attitudes and Divergent Opinions

The questionnaire, which included 334 U.S. physicians from primary care, neurology, intensive care, and anesthesiology, revealed nuanced positions. About 70.7 % supported the use of blood anticoagulants before death to improve preservation outcomes, while only 44.3 % approved initiating preservation before cardiac arrest in emergency scenarios. This split shows a willingness to adopt measures that may enhance preservation quality, yet a clear hesitation to intervene before actual death. Regarding the plausibility of future revival, 27.9 % considered it "somewhat reasonable" or "very reasonable," whereas the majority expressed varying degrees of skepticism. The data illustrate that the idea is still met with cautious interest that demands stronger empirical evidence before becoming a clinical norm.

## Technical and Legal Obstacles

One of the most prominent technical barriers is rapid blood clot formation after cardiac arrest, which can obstruct cryoprotectant flow through the vasculature and diminish neuronal preservation. Moreover, no jurisdiction currently permits the legal use of anticoagulants before death, limiting the ability to conduct large‑scale clinical trials. Technically, achieving uniform cryoprotectant distribution throughout the brain—often referred to as "homogeneous perfusion"—remains unresolved, and precise control of ultra‑rapid cooling is required to avoid cellular damage. These challenges make it difficult to forecast a realistic timeline for widespread human revival.

## Future Prospects and Potential Scenarios

Despite present limitations, researchers are exploring several promising avenues. Nanoparticle‑based cryoprotectants could improve tissue penetration, while gene‑editing techniques might increase cellular resistance to extreme cold. Animal studies have begun to show partial restoration of neural function after prolonged vitrification and thawing. Ethically, the prospect of reviving the dead raises questions about consent, post‑mortem rights, and societal impacts of a technology that could fundamentally alter the definition of life. If scientific breakthroughs eventually overcome the technical and regulatory hurdles, death might be re‑characterized as a reversible phase rather than an absolute endpoint. However, such a shift would require robust international governance and a medical community prepared to evaluate both risks and benefits.